Skip to main content
. 2014 Mar 26;8(5):956–967. doi: 10.1016/j.molonc.2014.03.005

Table 2.

IC50 (μM) of pancreatic cell lines treated with different compounds for 24 h.

Drugs Cell line
AsPC‐1 BxPC‐3 KCM MiaPaCa‐2 PANC‐1 CFPAC‐1
IC50 ± SEM IC50 ± SEM IC50 ± SEM IC50 ± SEM IC50 ± SEM IC 50 ± SEM
SW IV‐134 9.2 ± 0.4 6.8 ± 0.2 9.3 ± 0.2 7.8 ± 0.3 6.3 ± 0.1 7.4 ± 0.3
SW 43 + SW IV‐52s 54.8 ± 1.9 40.8 ± 1.2 53.8 ± 0.4 65.3 ± 0.9 13.4 ± 0.2 27.2 ± 2.3
SW 43 56.8 ± 2.8 56.3 ± 0.8 65.3 ± 1.0 81.8 ± 1.3 21.4 ± 0 48.2 ± 1.7
SW IV‐52s >300 >300 >300 >300 >300 >300

(Mean ± SEM), n ≥ 3. P < 0.05.